| Sign In to gain access to subscriptions and/or personal tools. |
RET/PTC Rearrangement Occurring in Primary Peritoneal CarcinomaDepartment of Histopathology, Trinity College Medical School, Dublin, Ireland, flavinr{at}tcd.ie
Institute of Molecular Radiobiology, GSF-National Research Centre for Environment and Health, Neuherberg, Germany
Department of Histopathology, Trinity College Medical School, Dublin, Ireland
Department of Histopathology, Trinity College Medical School, Dublin, Ireland
Department of Histopathology, Trinity College Medical School, Dublin, Ireland
Department of Histopathology, Trinity College Medical School, Dublin, Ireland
Department of Histopathology, Trinity College Medical School, Dublin, Ireland
Institute of Molecular Radiobiology, GSF-National Research Centre for Environment and Health, Neuherberg, Germany
Department of Histopathology, Trinity College Medical School, Dublin, Ireland
Department of Histopathology, Trinity College Medical School, Dublin, Ireland
Department of Histopathology, Trinity College Medical School, Dublin, Ireland
Department of Pathology, Bologna University School of Medicine, Bologna, Italy
Department of Histopathology, Trinity College Medical School, Dublin, Ireland
Department of Histopathology, Trinity College Medical School, Dublin, Ireland
Institute of Molecular Radiobiology, GSF-National Research Centre for Environment and Health, Neuherberg, Germany
Department of Histopathology, Trinity College Medical School, Dublin, Ireland RET/PTC rearrangements are initiating events in the development of a significant proportion of papillary thyroid carcinomas. Activated RET/PTC mutations are thought to be restricted to thyroid disease, but this study proposes that these events may also occur in nonthyroid tumors. A total of 57 nonthyroid papillary tumors were examined for RET/PTC rearrangements using interphase fluorescence in situ hybridization, Taqman reverse transcriptase polymerase chain reaction, and immunohistochemistry. Taqman single nucleotide polymorphism detection was used to analyze for expression of mutated BRAF T1799A. In all, 20% (3/15) of primary peritoneal carcinoma had detectable RET/PTC1 rearrangements by all 3 methodologies. A further case of similar histotype had an alternate RET/ PTC rearrangement. No RET/PTC1 rearrangements were detected in the remaining tumor cohort. All 57 tumors were homozygous for wild-type BRAF. The results indicate that RET/PTC rearrangements occur in a small subset of nonthyroid papillary tumors. These rearrangements may not be directly implicated in tumor growth; rather representing "passenger" mutations reflecting RET instability in secondary tumor subclones.
Key Words: RET RET/PTC1 peritoneal serous carcinoma fluorescence in situ hybridization (FISH) reverse transcriptase polymerase chain reaction (RT-PCR)
This version was published on June
1, 2009 International Journal of Surgical Pathology, Vol. 17, No. 3,
187-197 (2009) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

